CYTK
Cytokinetics Inc
67.60$
-1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +657.4% | -375.2% | – | – | – | -1,693.7% | – | – | – | – | |
| – | +20.2% | +25.8% | +159.1% | -35.5% | +4.4% | +41.6% | +24.3% | +155.4% | +104.5% | -19.9% | +6.2% | |
| – | +37.1% | +56.5% | +26.3% | +8.1% | +10.2% | +63.8% | +52.3% | +78.3% | +50.6% | +35.8% | +14.8% | |
| – | +36.8% | +68.5% | +17.0% | +8.9% | +19.6% | +102.8% | +43.4% | +131.5% | – | – | – | |
| – | – | -67.4% | -96.0% | -4,809.7% | – | – | -90.5% | -392.1% | – | +1,054.5% | -199.9% | |
| – | -49.1% | +184.0% | +80.3% | -69.1% | +194.6% | +322.0% | +342.2% | -76.8% | -87.5% | +175.8% | +535.1% | |
| – | – | -424.2% | +26.4% | – | -1,555.4% | +163.0% | -24.8% | +77.4% | – | -331.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -81.6% | -79.0% | +6,570.7% | -97.4% | +1,062.9% | -106.0% | +97.3% | – | -159.9% | – | – | |
| – | +0.0% | +0.7% | -91.6% | +684.9% | -82.7% | +19,470.8% | +0.0% | +41.5% | -100.2% | +1,021.0% | – | |
| – | -51.1% | -29.4% | +1,237.4% | -94.2% | +1,116.8% | +46.5% | +36.7% | +61.3% | -57.1% | +320.5% | -43.6% | |
| – | +78,603.5% | -96.0% | +3,144.3% | -242.2% | – | – | -36.2% | -253.2% | – | -139.3% | – | |
| – | – | +718.9% | -395.7% | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.